Skip to main content

Year: 2021

Exela Technologies Announces New Digital Mailroom Relationship with LPG, a Leading Debt Relief Law Firm

IRVING, Texas, Nov. 22, 2021 (GLOBE NEWSWIRE) — Exela Technologies, Inc. (“Exela” or “the Company”) (NASDAQ: XELA), a global business process automation leader, today announced a new Digital Mailroom (DMR) relationship with LPG, the nation’s leading debt relief law firm for individual consumers. Exela’s DMR is an end-to-end document management system that digitizes mail and other documents to create searchable, shareable digital assets that can be automatically routed to individual or group recipients, fully tracked, and made accessible via a secure web-based portal, from anywhere at any time. The DMR platform leverages Intelligent Document Processing (IDP) to significantly improve efficiency and accelerate digital transformation. “When working with original creditors, timeliness and compliance are of paramount importance,” noted...

Continue reading

Three Valley Copper Announces Senior Debt Forbearance Agreement Undertaking

/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION ORDISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES./ TORONTO, Nov. 22, 2021 (GLOBE NEWSWIRE) — (TSXV: TVC) Three Valley Copper Corp. (“Three Valley Copper” or the “Company”) announces that an undertaking (the “Undertaking”) has been entered into between the Company and the senior secured lenders (the “Lenders”) of Minera Tres Valles (“MTV”), the Company’s primary asset that is 91.1% owned located near Salamanca, Region de Coquimbo, Chile. The Company, together with its direct and indirectly wholly owned subsidiaries including MTV, and the Lenders (together, the “Parties”) have undertaken to execute a definitive binding agreement on or before September 30, 2022, to revise the loan repayment schedule as...

Continue reading

PURA Forecasts $1 Million 2022 Revenue From New Farmersville Hemp Brand

Dallas, TX, Nov. 22, 2021 (GLOBE NEWSWIRE) — Puration, Inc. (OTC Pink: PURA) today announced the company is initially forecasting $1 million in revenue for 2022.  Management believes the forecast is conservative and anticipates potentially revisiting the revenue forecast more than once next year. CEO Brian Shibley last week published an update outlining three target sources of revenue.  The letter has been republished below in its entirety: Dear Shareholders – We have just entered the fourth quarter of 2021 which we expect to be a pivotal period catapulting the company’s new Farmersville Hemp Brand into 2022 to begin generating and rapidly growing revenue. Yes, Covid hindered our transition, but it didn’t stop it and we are confident the Covid hurdles are now behind us. Central to our Farmersville Hemp Brand strategy is the Farmersville...

Continue reading

Seer to Participate in the Piper Sandler Virtual Healthcare Conference

REDWOOD CITY, Calif., Nov. 22, 2021 (GLOBE NEWSWIRE) — Seer, Inc., (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced that the company will participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference. A pre-recorded presentation will be available on the conference website beginning on November 22, 2021. A link to the presentation will also be available on the Investors section of the company’s website at investors.seer.bio. Seer will be participating in investor meetings at the Piper Sandler Healthcare Conference on Wednesday, December 1, 2021 and Thursday, December 2, 2021. About SeerSeer™ is a life sciences company developing transformative products that open a new gateway to the proteome. Seer is commercializing its Proteograph™ Product Suite, an integrated...

Continue reading

Shockwave Medical Enrolls First Patient in Disrupt BTK II Study for Long, Calcified, Below the Knee Lesions

Global Post-Market Study Will Assess Long-Term Benefit of Peripheral IVL on the Most Challenging Calcified Lesions, Including Patients with Critical Limb Ischemia SANTA CLARA, Calif., Nov. 22, 2021 (GLOBE NEWSWIRE) — Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely calcified cardiovascular disease, today announced the start of the Disrupt BTK II post-market study to assess the safety, effectiveness and optimal clinical use of the Shockwave Peripheral IVL System for the treatment of calcified peripheral lesions below the knee (BTK), including some of the most challenging patients with critical limb ischemia (CLI). Disrupt BTK II is a post-market, prospective, multicenter, single-arm study led by Ehrin Armstrong, M.D., Medical Director and Interventional Cardiologist,...

Continue reading

Akoya Biosciences to Host Inaugural Spatial Day on December 15, 2021

The program will highlight the latest breakthroughs and applications in spatial biology and the company’s latest innovations to accelerate breakthroughs in discovery and clinical research. MARLBOROUGH, Mass., Nov. 22, 2021 (GLOBE NEWSWIRE) — Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced that it will host an inaugural Spatial Day on December 15, 2021 at 12 p.m. ET. The program will feature Akoya speakers and experts at the forefront of this new field who will discuss how spatial biology is uniquely positioned to address challenges in discovery, translational and clinical research, where the field is headed, and Akoya’s vision for the future. Akoya is a pioneer in the rapidly emerging field of spatial phenotyping, a transformational new application that is giving unprecedented context...

Continue reading

Cue Biopharma to Present at the Piper Sandler 33rd Annual Healthcare Conference

CAMBRIDGE, Mass., Nov. 22, 2021 (GLOBE NEWSWIRE) — Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company engineering a novel class of injectable biologics designed to selectively engage and modulate targeted T cells within the patient’s body, announced today that it participated in a pre-recorded fireside chat as part of the Piper Sandler 33rd Annual Virtual Healthcare Conference, being held on November 29-December 2, 2021. The pre-recorded presentation will be available to participants during the conference and on the Events page of the Investor & Media section of the Company’s website www.cuebiopharma.com beginning today, November 22, 2021 at 10:00 a.m. EST. An archived version of the recording will be accessible for 90 days following the event. About Cue BiopharmaCue Biopharma, a clinical-stage biopharmaceutical...

Continue reading

Antares Pharma to Participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference

EWING, N.J., Nov. 22, 2021 (GLOBE NEWSWIRE) — Antares Pharma, Inc. (NASDAQ: ATRS) (the “Company”), a specialty pharmaceutical company, today announced that Robert F. Apple, President and Chief Executive Officer, is scheduled to virtually present and host investor meetings at the Piper Sandler 33rd Annual Virtual Healthcare Conference being held on November 29-December 2, 2021. A pre-recorded webcast of the fireside chat will be available under the “For Investors” section of the Antares Pharma website at www.antarespharma.com beginning on Monday, November 22 at 10am ET. About Antares Pharma Antares Pharma, Inc. is a specialty pharmaceutical company focused primarily on the development and commercialization of self-administered injectable pharmaceutical products using advanced drug delivery auto injector technology. The Company has...

Continue reading

PMV Pharma to Present at the Evercore ISI 4th Annual HealthCONx Conference

CRANBURY, N.J., Nov. 22, 2021 (GLOBE NEWSWIRE) — PMV Pharmaceuticals, Inc. (Nasdaq: PMVP), a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies targeting p53 mutants, today announced that David H. Mack, Ph.D., President & Chief Executive Officer, will represent PMV Pharma in a “Fireside Chat” at the Evercore ISI 4th Annual HealthCONx Conference taking place November 30 – December 2, 2021. The company will also participate in one-on-one investor meetings at the conference. Details on the presentation can be found below.Evercore ISI 4th Annual HealthCONx ConferenceDate: Thursday, December 2, 2021Time: 11:20 am ETFormat: Fireside ChatAbout PMV Pharma PMV Pharma is a precision oncology company pioneering the discovery and development of small molecule,...

Continue reading

Whole Earth Brands, Inc. to Participate in the Canaccord Genuity AgriFood Tech Innovations Virtual Forum

CHICAGO, Nov. 22, 2021 (GLOBE NEWSWIRE) — Whole Earth Brands, Inc. (the “Company”) (Nasdaq: FREE), a global food company enabling healthier lifestyles, today announced that Albert Manzone, Chief Executive Officer, will host a presentation at the Canaccord Genuity AgriFood Tech Innovations Virtual Forum on Thursday, December 2nd at 12:30 pm ET. The live audio webcast will be accessible in the News & Events section on the Company’s Investor Relations website at investor.wholeearthbrands.com. An archived replay of the webcast will also be available shortly after the live event has concluded. About Whole Earth Brands Whole Earth Brands is a global food company enabling healthier lifestyles and providing access to premium plant-based sweeteners, flavor enhancers and other foods through our diverse portfolio of trusted brands...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.